newsfilter
← Latest News
GlobeNewswire·

ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases

ERYTECH Expands Patent Portfolio for the Treatment of Rare Metabolic Diseases Cambridge, MA (U.S.) and Lyon (France), February 8, 2022 – ERYTECH Pharma (NASDAQ:ERYP), a clinical-stage biopharmaceutical company developing innovative therapies by